PHS
PMVP icon

PFM Health Sciences’s PMV Pharmaceuticals PMVP Stock Holding History

PFM Health Sciences’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,301,942
Closed -$3.6M – 69
2025
Q1 		$3.6M Buy
3,301,942
+1,222,697
+59% +$1.66M 0.26% 46
2024
Q4 		$3.14M Buy
2,079,245
+68,205
+3% +$108K 0.19% 63
2024
Q3 		$3M Buy
2,011,040
+735,578
+58% +$1.14M 0.17% 61
2024
Q2 		$2.07M Hold
1,275,462
– – 0.1% 69
2024
Q1 		$2.17M Sell
1,275,462
-197,551
-13% -$369K 0.1% 81
2023
Q4 		$4.57M Buy
1,473,013
+177,909
+14% +$471K 0.27% 53
2023
Q3 		$7.95M Buy
1,295,104
+1,066,694
+467% +$7.33M 0.37% 58
2023
Q2 		$1.43M Sell
228,410
-189,617
-45% -$994K 0.06% 79
2023
Q1 		$1.99M Buy
418,027
+84,311
+25% +$593K 0.09% 72
2022
Q4 		$2.9M Sell
333,716
-521,448
-61% -$5.56M 0.1% 77
2022
Q3 		$10.2M Sell
855,164
-359,000
-30% -$5.19M 0.37% 63
2022
Q2 		$17.3M Buy
1,214,164
+767,864
+172% +$11.2M 0.66% 50
2022
Q1 		$9.29M Buy
446,300
+157,966
+55% +$2.79M 0.35% 55
2021
Q4 		$6.66M Hold
288,334
– – 0.23% 61
2021
Q3 		$8.59M Hold
288,334
– – 0.25% 65
2021
Q2 		$9.85M Buy
+288,334
New +$9.63M 0.31% 64

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

PFM Health Sciences's PMVP Position: Q2 2025 in Review

PFM Health Sciences sold out of PMV Pharmaceuticals (PMVP) in Q2 2025, closing a stake of 3,301,942 shares — an estimated $3.6M sold.

PFM Health Sciences first reported a position in PMVP in Q2 2021 and held it in 16 quarters. The position peaked at $17.3M in Q2 2022. 54 funds tracked by Wall St. Rank hold PMVP as of Q2 2025.

  • PFM Health Sciences reported no remaining PMV Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • PFM Health Sciences sold 3,301,942 PMV Pharmaceuticals shares in Q2 2025, an estimated $3.6M.
  • PFM Health Sciences first reported a position in PMV Pharmaceuticals in Q2 2021 and held it in 16 quarters.
  • PFM Health Sciences's PMV Pharmaceuticals position peaked at $17.3M in Q2 2022.
  • 54 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2025.

Based on PFM Health Sciences's 13F filing for Q2 2025, filed 14 Aug 2025.